SCHEMBL19549148

SCHEMBL19549148

CC(C)CC(C(=O)N1CCCCC1)N(C)Cc1cc(C(=O)O)ccn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4C Q9H3R0 8/20 0.41
▸ KDM5C P41229 3/20 0.41
▸ LNPEP Q9UIQ6 2/20 0.40
▸ KDM5B Q9UGL1 9/20 0.39
▸ KDM5A P29375 7/20 0.36
▸ KDM2B Q8NHM5 3/20 0.36
▸ KDM4A O75164 3/20 0.36
▸ KDM6B O15054 2/20 0.36
▸ PROKR1 Q8TCW9 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ TET3 O43151 1/20 0.35
▸ BBOX1 O75936 1/20 0.35
▸ ASPH Q12797 1/20 0.35
▸ KDM4D Q6B0I6 1/20 0.35
▸ TET2 Q6N021 1/20 0.35
▸ ALKBH5 Q6P6C2 1/20 0.35
▸ KDM7A Q6ZMT4 1/20 0.35
▸ KDM8 Q8N371 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16291620 1.00 KDM4C (0.41) KDM4CKDM5CLNPEPKDM5BKDM5A
SCHEMBL19676439 0.90 KDM4C (0.39) KDM4CKDM5CLNPEPKDM5BKDM5A
SCHEMBL19676438 0.86 LNPEP (0.38) LNPEPALDH1A1MAPTKDM4E
SCHEMBL15637002 0.76 KDM4C (0.41) KDM4CKDM5CLNPEPKDM5BKDM5A
SCHEMBL16291664 0.75 KDM4C (0.43) KDM4CKDM5CKDM5BKDM5AKDM2B
SCHEMBL15637391 0.72 KDM4C (0.44) KDM4CKDM5CKDM5BKDM5AKDM2B
SCHEMBL19676375 0.71 KDM4C (0.43) KDM4CKDM5CKDM5BKDM5AKDM2B
SCHEMBL16291490 0.70 HRH3 (0.45) KDM4CKDM5CKDM5BKDM5AKDM2B
SCHEMBL17144854 0.70 KMT2A (0.41) KDM4CKDM5CKDM5BKDM5AKDM2B
SCHEMBL17144856 0.70 KDM5C (0.44) KDM4CKDM5CKDM5BKDM5AKDM2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10221139-B2 Inhibitors of histone demethylases GILEAD SCIENCES, INC. (US) 2019-03-05 — — US disclosed
US-20170320827-A1 INHIBITORS OF HISTONE DEMETHYLASES GILEAD SCIENCES, INC. 2017-11-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170320827-A1 INHIBITORS OF HISTONE DEMETHYLASES EHMT1, KDM1B, EHMT2 KDM4C 56/4885KDM5C 31/4885LNPEP 2360/4885
US-10221139-B2 Inhibitors of histone demethylases EHMT1, KDM1B, EHMT2 KDM4C 56/4885KDM5C 31/4885LNPEP 2360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback